Company / Current Assets
RIGEL PHARMACEUTICALS INC Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$240.2M
FY2025
5-year range
$99.3M / $240.2M
FY2021-FY2025
Trend
+77.8%
vs FY2024
Sector context
#181 of 213
Health Care
What the data says
RIGEL PHARMACEUTICALS INC's current assets of $240M is lower than 85% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 10 years, ranging from $76M in FY2016 to $240M in FY2025.
Based on SEC 10-K filings.
$240M in FY2025 with a 5-year CAGR of +22.0%.
Improved from $99M to $240M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +27.5%
- 5-Year CAGR
- +22.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 213This company $240.2M Sector average $2.5B
▼
-90.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +22.0%, indicating consistent growth.
- In FY2025, current assets increased 77.8% year-over-year.
- Ranks #181 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $240.2M | +77.8% |
| FY2024 | $135.1M | +36.1% |
| FY2023 | $99.3M | -14.4% |
| FY2022 | $115.9M | -25.0% |
| FY2021 | $154.5M | +73.6% |
| FY2020 | $89.0M | -25.2% |
| FY2019 | $119.0M | -13.1% |
| FY2018 | $137.0M | +16.7% |
| FY2017 | $117.4M | +54.1% |
| FY2016 | $76.2M | -40.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026